Skip to main content
FinSpry Logo
FinSpry
LENZ logo
LENZ
(NASDAQ)
LENZ Therapeutics, Inc.
$7.20-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

LENZ Therapeutics (LENZ) Stock Price & Financial Analysis

LENZ Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$6.61 - $6.99
52-Week High$50.40
52-Week Low$6.83
Open$6.83
Volume711.37K
Average Volume (3M)856.72K
Market Cap191.61M
Shares Outstanding28.81M
Price to Sales (P/S)10.04
Price to Book (P/B)0.67
EV/EBITDA-1.84
Revenue (TTM)19.09M
Net Income (TTM)-82.13M
Free Cash Flow (TTM)-70.00M
EPS (TTM)$-2.85
Profit Margin-430.25%
Operating Margin-477.46%
Return on Equity (ROE)-28.88%
Debt to Equity0.00
50-Day MA$10.14
200-Day MA$23.78
52-Week Change-65.99%
Annual Dividend$0.00
Dividend Yield0.00%
Last Dividend Ex-DateMar 22, 2024

Frequently Asked Questions About LENZ Therapeutics

What is the current stock price for LENZ?

As of the latest trading session, LENZ stock trades at $6.65. The 52-week range is $6.83–$50.40, with a day range of $6.61–$6.99.

What is the P/E ratio for LENZ?

The P/E ratio (Price-to-Earnings) for LENZ is shown in the Key Statistics section. This valuation metric helps compare LENZ Therapeutics, Inc. to industry peers.

Does LENZ pay dividends?

LENZ Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for LENZ?

Based on 3 analysts, the consensus for LENZ is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of LENZ?

LENZ Therapeutics's market capitalization is $191.6M, classifying it as a micro-cap company. LENZ Therapeutics operates in the Healthcare sector within the Biotechnology industry.